Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
NCT00373347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 573
Last updated 2026-04-17
Summary
The purpose of this study is to identify blood markers that have the ability to diagnose liver cancer with improved accuracy, so that it can be used alone or in conjunction with alpha-feto protein (AFP)
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Samuel So · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-30
- Primary Completion
- 2024-11-18
- Completion
- 2024-11-18
Countries
- United States
Study Locations
More Related Trials
-
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
NCT00912847 ·Status: COMPLETED
-
HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC
NCT03020342 ·Status: UNKNOWN
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
Searching for the Liver Cancer-Related Biomarkers
NCT00154544 ·Status: UNKNOWN
-
Epidemiologic Study of Hepatocellular Carcinoma in the US
NCT02358070 ·Status: COMPLETED
-
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
NCT01963949 ·Status: WITHDRAWN
-
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
NCT01316679 ·Status: COMPLETED
-
B-mode Ultrasound Imaging in Detecting Early Liver Cancer
NCT02774161 ·Status: COMPLETED ·Phase: NA
-
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
NCT04221347 ·Status: UNKNOWN
-
Detect and Expunge Concealed Tumors of the Liver
NCT06141564 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING
-
Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis
NCT02973516 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial Multi-analyte Blood Test
NCT03694600 ·Status: UNKNOWN
-
A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma
NCT07265271 ·Status: RECRUITING
-
Development of a Novel Biomarker for Liver Fibrosis
NCT02348814 ·Status: COMPLETED
-
Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma
NCT00842647 ·Status: UNKNOWN
-
Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.
NCT02826005 ·Status: UNKNOWN ·Phase: NA
-
Study of Serum Tumor Markers of HBV Associated HCC
NCT05825196 ·Status: NOT_YET_RECRUITING
-
Phenotyping Liver Cancer Registry
NCT04681274 ·Status: COMPLETED
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark
NCT00902902 ·Status: UNKNOWN
-
Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma
NCT02541149 ·Status: COMPLETED
-
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
NCT05064553 ·Status: ACTIVE_NOT_RECRUITING
-
Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
NCT03878550 ·Status: ACTIVE_NOT_RECRUITING